The rate at which the epidemic of acquired immune deficiency syndrome (AIDS) is spreading in North America, Asia, Latin America, and Africa is discussed. The number of people infected globally and in low-risk urban populations is presented. (KR)

Selected for discussion are certain advances in basic research and technologic innovation which shape the past, present, and future of medical care. Included are infectious diseases, especially hepatitis, immunology, clinical disorders of the immune system and the histocompatability system. (Author/SA)

Claims that the lifetime cost of medicare per acquired immune deficiency syndrome (AIDS) patient will not exceed $80,000, an amount similar to the cost of treating other serious illnesses. Argues that the total projected costs for treating AIDS patients between 1981 and 1991 will not exceed $22 billion. (TW)

Provides an overview of some major areas of legal concern in which the acquired immune deficiency syndrome (AIDS) epidemic is having an impact. Reviews rights of confidentiality and nondiscrimination regarding access to health care, employment, housing, education, and insurance. (TW)

Discusses a number of obstacles that limit effective education for reducing the incidence of acquired immune deficiency syndrome (AIDS) in the United States. Includes behaviors that must be changed, disagreement about the propriety of educational messages to prevent AIDS, and uncertainty as to some of the dual messages of reassurance being…

Discusses how the infection of the human immunodeficiency virus (HIV) results in a profound immunosuppression due predominantly to a selective depletion of helper/inducer T lymphocytes that express the receptor for the virus, as well as neuropsychiatric abnormalities in the brain. (TW)

Discusses some of the worldwide problems associated with the acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus type 1 (HIV-1). Calls for programs for the prevention and control of AIDS as an immediate priority in all countries. (TW)

Reports that by the end of 1987, nearly 50,000 cases of acquired immune deficiency syndrome (AIDS) had been reported in the United States since 1981, with 20,745 in 1987 alone. Discusses the disordinate proportion of cases involving black and Hispanic adults and children. (TW)

Discusses the complicated infection of human immunodeficiency virus type 1 (HIV-1) in its late stages of the acquired immune deficiency syndrome (AIDS) dementia complex. Explains the syndrome's development of abnormalities in cognition, motor performance, and behavior. (TW)

Poses questions about how we can control the acquired immune deficiency syndrome (AIDS) epidemic and the harm that it causes without unjustly discriminating against particular social groups and without unnecessarily infringing on the freedom of individuals. (TW)

Reports on a movement conducted by social workers to decrease the infection of the Acquired Immune Deficiency Syndrome by changing human behavior through public education. Stresses that the focus is to draw attention to behavior modification. (RT)

Discussed are novel ways of blocking gene expression by using antisense RNA. The use of antisense technology in plant development and its possible use in human disease therapy are described. (KR)

Discusses insights discovered from research into human biology that are raising possibilities for therapy, prevention of disease, and challenges to society in the form of ethical decisions about the appropriate application of genetic information. (Author/RT)

Provides an overview of basic and applied studies for which primates are appropriate subjects. Summarizes the advantages, limitations, and constraints of using nonhuman primates in research. (RT)